Surgeons specializing in laparoscopic procedures at UT Southwestern Medical Center have successfully removed a patient’s kidney by performing a unique nephrectomy entirely through the belly button.

A relatively new, minimally invasive treatment was 93 percent successful in eradicating malignant kidney tumors, according to a recent study conducted by researchers from Wake Forest University Baptist Medical Center in Winston-Salem, NC.

Clinicians currently lack advance warning of acute kidney injury (AKI) for patients where kidney injury timing is unknown. Now paediatric research published in the open access journal, Critical Care, has identified a potential biomarker to predict AKI earlier than current tests, opening a vital window for prevention of this life-threatening condition.

Massachusetts General Hospital (MGH) researchers have identified a key mechanism underlying proteinuria – excess protein in the urine which signifies a breakdown in the kidney’s filtering process.

A relatively new, minimally invasive treatment was 100 percent successful in eradicating small malignant kidney tumors in a study of more than 100 patients, report researchers from Wake Forest University Baptist Medical Center.

A combination of two types of blood pressure-lowering drugs—an angiotensin-converting enzyme inhibitor plus an angiotensin-receptor blocker, added to enzyme replacement therapy with agalsidase-beta —is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of American Society of Nephrology.

Researchers from the European Molecular Biology Laboratory (EMBL) and the University of Michigan have discovered a gene that protects us against a serious kidney disease. In the current online issue of Nature Genetics they report that mutations in the gene cause nephronopthisis (NPHP) in humans and mice.

A new Wesley Research Institute project aims to make it much easier for people to manager their Type 2 Diabetes by using community pharmacists.

A blood component called cystatin C, used to test for early-stage kidney impairment, also may be a very early marker for those at risk of developing a condition known as pre-diabetes, a study conducted by researchers at the University at Buffalo has shown.

The most common procedure for clearing blocked kidney arteries can also release thousands of tiny particles into the bloodstream that can impair kidney function, according to researchers from Wake Forest University Baptist Medical Center and colleagues.

University of Pittsburgh School of Medicine investigators have engineered artificial blood vessels from muscle-derived stem cells (MDSCs) and a biodegradable polymer that exhibit extensive remodeling and remain free of blockages when grafted into rats.

Event to Feature 'Kidney-Friendly' Favorites From Bongos Cuban Cafe in Miami